Literature DB >> 13618540

Haemoglobinuria caused by propylene glycol in sheep.

B J POTTER.   

Abstract

HAEMOGLOBINURIA OCCURRED IN SHEEP ANAESTHETIZED BY AN INTRAVENOUS INJECTION OF PENTOBARBITONE SODIUM CONTAINING PROPYLENE GLYCOL: an equivalent dose failed to cause haemoglobinuria in rabbits. Intravenous injection of an aqueous solution of 20% propylene glycol caused haemoglobinaemia and haemoglobinuria in sheep. Neither distilled water nor 20% glycerol in water administered under identical conditions produced these effects.Haemoglobinuria occurred on some occasions when an aqueous 20% solution of propylene glycol was administered to sheep after an injection of saline: it never occurred when a solution of 20% propylene glycol prepared with physiological saline was injected. It is suggested that saline may protect against the haemolytic action of propylene glycol in sheep and that propylene glycol should be avoided as a menstruum for pharmaceutical preparations to be used for injection into the blood stream of these animals.

Entities:  

Keywords:  GLYCOLS/effects; HEMOGLOBINURIA

Mesh:

Substances:

Year:  1958        PMID: 13618540      PMCID: PMC1481873          DOI: 10.1111/j.1476-5381.1958.tb00225.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  3 in total

1.  Observations on the potential across the rumen of the sheep.

Authors:  H G Ferreira; F A Harrison; R D Keynes; A H Nauss
Journal:  J Physiol       Date:  1966-12       Impact factor: 5.182

2.  Propylene glycol-induced side effects during intravenous nitroglycerin therapy.

Authors:  H E Demey; R A Daelemans; G A Verpooten; M E De Broe; C M Van Campenhout; F V Lakiere; P J Schepens; L L Bossaert
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

3.  Intravenous Infusions of Glycerol Versus Propylene Glycol for the Regulation of Negative Energy Balance in Sheep: A Randomized Trial.

Authors:  Mugagga Kalyesubula; Alexander Rosov; Tamir Alon; Uzi Moallem; Hay Dvir
Journal:  Animals (Basel)       Date:  2019-09-26       Impact factor: 2.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.